EasySep™ Human Naïve B Cell Enrichment Kit

Cell Isolation Naive B cell

Experiment
Cell Isolation Naive B cell
Product
EasySep™ Human Naïve B Cell Enrichment Kit from STEMCELL technologies
Manufacturer
STEMCELL technologies

Protocol tips

Protocol tips
CD10+ immature/transitional B cells were subsequently depleted using magnetic beads (CD10+ Positive Selection beads, Stem Cell Technologies). Naïve B cell stimulations were performed in complete RPMI medium using Staphylococcus aureus Cowan I (SAC, Sigma) + 200U/ml rIL-2 (Peprotech), anti-IgM F(ab’)2 (Jackson Immunoresearch, 25 μg/ml) −/+anti-CD40 (1 μg/ml) or recombinant human BAFF (200 ng/ml) (R&D Systems).

Publication protocol

Patient’s and biological parents’ blood/tissue samples were obtained after written informed consent through protocols established by the Pediatric Oncology Branch and the Lymphocyte Molecular Genetics Unit and approved by the Institutional Review Boards (IRB) of the National Institutes of Health (NIH). The parents separately provided consent for a single-patient clinical protocol that was approved by the University of Kentucky IRB. Anonymized buffy coat samples from healthy normal donors were provided by the NIH Blood Bank. Jurkat T cell (E6 and JPM50.6) and BJAB B cell lines were maintained in complete RPMI medium (RPMI 1640 (Lonza) supplemented with 10 % fetal bovine serum (FBS), 2 mM glutamine, and 100 U/ml each of penicillin and streptomycin (Invitrogen)). Peripheral blood mononuclear cells (PBMC) were isolated from whole blood or buffy coats using Ficoll-Hypaque-PLUS (Roche) density gradient centrifugation. Following erythrocyte lysis in ACK buffer (Lonza), pan T cells or naïve B cells were purified by negative selection using magnetic bead sorting kits (EasySep Human T cell Enrichment Kit, EasySep Human Naïve B cell Enrichment Kit, Stem Cell Technologies). CD10+ immature/transitional B cells were subsequently depleted using magnetic beads (CD10+ Positive Selection beads, Stem Cell Technologies). Naïve B cell stimulations were performed in complete RPMI medium using Staphylococcus aureus Cowan I (SAC, Sigma) + 200U/ml rIL-2 (Peprotech), anti-IgM F(ab’)2 (Jackson Immunoresearch, 25 μg/ml) −/+anti-CD40 (1 μg/ml) or recombinant human BAFF (200 ng/ml) (R&D Systems). For ELISA and plasmablast assays, naïve B cells were stimulated with either anti-IgM F(ab’)2 (Jackson Immunoresearch, 10 μg/ml) or dextran-coupled anti-IgD or anti-IgM (Fina Biosolutions, 100 ng/ml) plus 1 μg/ml anti-CD40 (R&D Systems) and 10 ng recombinant human IL-21 (BioLegend). T cells were stimulated with 2 μg/ml each of anti-CD3ε and anti-CD28 mAbs (BD Biosciences) or MACS iBead particles (1:1 bead:cell ratio) loaded with biotinylated anti-CD2, anti-CD3ε, and anti-CD28 Abs (Miltenyi Biotec) in complete RPMI.

Full paper   Login or join for free to view the full paper.

Reviews

EasySep™ Human Naïve B Cell Enrichment Kit from STEMCELL technologies has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing Cell Isolation Naive B cell using EasySep™ Human Naïve B Cell Enrichment Kit from STEMCELL technologies.

View full paper   Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from STEMCELL technologies for EasySep™ Human Naïve B Cell Enrichment Kit below.

Download PDF Download manufacturer protocol

Videos

Check out videos that might be relevant for performing Cell Isolation Naive B cell using EasySep™ Human Naïve B Cell Enrichment Kit from STEMCELL technologies. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms